Surrogate Measures and Consistent Surrogates
From MaRDI portal
Publication:2861938
DOI10.1111/BIOM.12071zbMath1429.62621OpenAlexW2134469398WikidataQ42858959 ScholiaQ42858959MaRDI QIDQ2861938
Publication date: 13 November 2013
Published in: Biometrics (Search for Journal in Brave)
Full work available at URL: http://europepmc.org/articles/pmc4221255
Related Items (12)
On the relationship between the causal‐inference and meta‐analytic paradigms for the validation of surrogate endpoints ⋮ Causal measures of the treatment effect captured by candidate surrogate endpoints ⋮ Evaluating multiple surrogate markers with censored data ⋮ Robust methods to correct for measurement error when evaluating a surrogate marker ⋮ Solutions for Surrogacy Validation with Longitudinal Outcomes for a Gene Therapy ⋮ Proportion of treatment effect mediated by surrogate endpoints ⋮ Robust Approach to Combining Multiple Markers to Improve Surrogacy ⋮ Testing for Heterogeneity in the Utility of a Surrogate Marker ⋮ Surrogate marker assessment using mediation and instrumental variable analyses in a case-cohort design ⋮ Evaluation of longitudinal surrogate markers ⋮ Assessing the value of a censored surrogate outcome ⋮ An information-theoretic approach for the evaluation of surrogate endpoints based on causal inference
Cites Work
- Unnamed Item
- Simple relations between principal stratification and direct and indirect effects
- Comparing Biomarkers as Principal Surrogate Endpoints
- Statistical Identifiability and the Surrogate Endpoint Problem, with Application to Vaccine Trials
- Principal Stratification in Causal Inference
- Evaluating Candidate Principal Surrogate Endpoints
- Related Causal Frameworks for Surrogate Outcomes
- On meta-analytic assessment of surrogate outcomes
- Augmented Designs to Assess Immune Response in Vaccine Trials
This page was built for publication: Surrogate Measures and Consistent Surrogates
